Lockheed Martin Israel Ltd. and Yissum Research Development Company Ltd., the technology transfer company of the Hebrew University of Jerusalem, have signed an agreement to conduct joint collaborative research. The collaboration will focus on basic and applicable scientific research in areas such as quantum information sciences and material sciences, and other areas.

A top US health agency is working with an Israeli start-up to develop solutions to ‘flesh-eating’ septic bio-threats

We are happy to share with you some of the exciting events of our Year of Jubilee. 
Shana Tova!

Hyrax licenses the technology for YIssum to produce new printers that will use silver-based inks for to revolutionize conductive printing. 

The first gateway for Korean companies to the world of Israeli Academic Innovation.  

The many groundbreaking products that came out of the labs of the Hebrew University of Jerusalem (HUJI) – including the blockbuster drugs Exelon and Doxil, as well as the hardy cherry tomato – may never have moved from academia to market without Yissum Research Development Company, founded in February 1964 to protect and commercialize HUJI’s intellectual property.

Jerusalem-based Mobileye’s IPO surpassed Partner Communication Ltd’s share sale of $525 million in October 1999 to become the biggest U.S. IPO by an Israeli company. Founded by Hebrew University professor Amnon Shashua and Ziv Aviram 15 years ago, Mobileye makes a chip and a system that alert drivers to pedestrians and unintended lane departures. The company’s products will help enable hands-free driving on the highway by 2016, according to the filing.

The funds will enable Atox Bio to initiate a late stage clinical study of AB103, for the treatment of necrotising soft tissue infections (NSTI), commonly referred to as the "flesh eating bacteria" and other severe infections. The study is expected to start in the second half of 2015.
AB103, an immunomodulator licensed from Yissum, the technology transfer company of the Hebrew University In Jerusalem, is a peptide that offers a unique approach in the treatment of infectious diseases by modulating, but not inhibiting, the host immune system.

Known as the Startup Nation, Israeli startups have now taken their expertise in innovation and technology to create revolutionary tools for the blind and visually impaired, two of them from Hebrew university researchers.

The next interim results expected at Q3 2015, following 2 years of treatment; final results expected at Q3 2016, following 3 years of treatment

With Michael Brandwein’s work on bacterial biofilm disruption, fresh fruits and vegetables can once again be safe

Take a look at some of the leading new Agricultural Technologies that will help feed the world in the coming decades.  

The next innovation that will feed you: Introducing the future of agriculture 

Ever notice how a spilled drop of coffee spreads into a ring stain on your shirt? The particle-filled liquid flows outward from the drop, leaving the particles on the rim of the ring as the liquid evaporates. This phenomenon posed big problems for printers. How do you keep drops of ink in place? Then Hebrew University Prof. Shlomo Magdassi realized it could actually provide a way to move the industry toward a fantastic future in functional printing.

Avi Hasson, Chief Scientist of Israel’s Ministry of Economy, said at the award ceremony: “Qlight Nanotech encompasses a winning combination of outstanding technology originating from the Hebrew University together with a leading international partner". 

Yissum displays some of the most exciting advances at NanoIsrael 2014 in Tel Aviv, an event that drew thousands from 30 countries.

Mobileye is planning an IPO at a colossal company valuation of $2.5-3 billion, according to financial news website Calcalist. If that is the case, Mobileye, which specializes in the development of Advanced Driver Assistance Systems (ADAS) for motor-vehicles, will offer up the largest ever IPO made by an Israeli company on NASDAQ. According to the report, the Israeli founders of Mobileye will attempt to raise $500 million at a company valuation of $2.5-3 billion.

If the eyes don’t work properly, the ears are an appropriate substitute for vision, according to Prof. Amir Amedi

These inks, developed by Prof. Shlomo Magdassi from the Casali Institute of Chemistry, allow printing nanoscale electronic circuits, cheap flexible displays, smart labels and posters and even active clothing.